WINNERS & LOSERS: Goodwin jumps; Oxford BioMedica trims revenue view
(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Friday. Read More
| Price | 279.50p on 28-08-2026 at 18:15:08 |
|---|---|
| Change | 0.50p 0.18% |
| Buy | 280.50p |
| Sell | 280.00p |
| Last Trade: | Sell 43,629.00 at 279.50p |
| Day's Volume: | 544,437 |
| Last Close: | 279.50p |
| Open: | 278.50p |
| ISIN: | GB00BD0NVK62 |
| Day's Range | 278.50p - 281.00p |
| 52wk Range: | 228.00p - 312.00p |
| Market Capitalisation: | £466.01m |
| VWAP: | 279.65561p |
| Shares in Issue: | 166.73m |
Hollywood Bwl (BOWL) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 43,629 | 279.50p | SI Trade |
16:38:57 - 28-Aug-26 |
| Sell* | 1,315 | 279.50p | SI Trade |
16:35:25 - 28-Aug-26 |
| Sell* | 361,867 | 279.50p | Uncrossing Trade |
16:35:25 - 28-Aug-26 |
| Buy* | 233 | 280.50p | Automatic Execution |
16:29:49 - 28-Aug-26 |
| Sell* | 47 | 280.00p | Automatic Execution |
16:29:11 - 28-Aug-26 |
| Sell* | 68 | 280.00p | Automatic Execution |
16:29:08 - 28-Aug-26 |
| Sell* | 55 | 280.00p | Automatic Execution |
16:28:50 - 28-Aug-26 |
| Sell* | 49 | 280.00p | Automatic Execution |
16:28:32 - 28-Aug-26 |
| Sell* | 81 | 280.00p | Automatic Execution |
16:27:38 - 28-Aug-26 |
| Sell* | 151 | 280.00p | Automatic Execution |
16:27:13 - 28-Aug-26 |
Hollywood Bwl (BOWL) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 3rd Aug 2026 7:00 am | RNS | Total Voting Rights |
| 28th Jul 2026 7:00 am | RNS | Transaction in Own Shares |
| 27th Jul 2026 12:50 pm | RNS | Director/PDMR Shareholding |
| 21st Jul 2026 7:00 am | RNS | Transaction in Own Shares |
| 14th Jul 2026 7:00 am | RNS | Transaction in Own Shares |
| 9th Jul 2026 7:05 am | RNS | Director Declaration |
| 9th Jul 2026 7:00 am | RNS | Transaction in Own Shares |
| 1st Jul 2026 7:00 am | RNS | Share Buyback Programme |
| 1st Jul 2026 7:00 am | RNS | Total Voting Rights |
| 8th Jun 2026 11:50 am | RNS | Director/PDMR Shareholding |